Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02440737 · ClinicalTrials.gov registry record · NA
Navigated Early Survivorship Transition in Patients With Newly Diagnosed Cancer and Their Caregivers
A NA study, sponsored by Vanderbilt-Ingram Cancer Center.
- Terminated
- Registry status
- NA
- Development phase
- 67
- Enrollment target
NCT02440737 is a NA study that was terminated before completion, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 67 participants.
The verdict
NCT02440737, a NA study, was terminated before completion, sponsored by Vanderbilt-Ingram Cancer Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 67 participants
- Enrollment target
Study Summary
This pilot clinical trial studies the Navigated Early Survivorship Transition (NEST) intervention in improving survivorship care planning in patients with newly diagnosed cancer and their caregivers. A survivorship care planning session (SCPS) delivered to survivors and their primary caregivers may improve psychosocial well-being, patient and caregiver engagement, and adherence to treatment and follow-up recommendations. It is not yet known whether a NEST intervention or usual care is better in improving survivorship care planning in patients with newly diagnosed cancer.
Interventions
- OTHER Questionnaire Administration
- OTHER Educational Intervention
- OTHER Follow-Up Care
- PROCEDURE Psychosocial Assessment and Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2015-05 |
| Est. Completion | 2018-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02440737
The ClinicalTrials.gov registry entry for NCT02440737 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt-Ingram Cancer Center, which has 189 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Questionnaire Administration is the first listed.
NCT02440737 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02440737 about?
NCT02440737 is a clinical study titled "Navigated Early Survivorship Transition in Patients With Newly Diagnosed Cancer and Their Caregivers". This pilot clinical trial studies the Navigated Early Survivorship Transition (NEST) intervention in improving survivorship care planning in patients with newly diagnosed cancer and their caregivers. A survivorship care planning session (SCPS) delivered to survivors and their primary caregivers may ...
What is the current status of trial NCT02440737?
This trial is currently terminated. It is a NA study. The enrollment target is 67 participants. The study started on 2015-05. Estimated completion is 2018-12.
What interventions are being tested in trial NCT02440737?
The interventions under investigation include: Questionnaire Administration (OTHER), Educational Intervention (OTHER), Follow-Up Care (OTHER), Psychosocial Assessment and Care (PROCEDURE).
Who is sponsoring clinical trial NCT02440737?
This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.